Zentalis Pharmaceuticals (NASDAQ:ZNTL) Trading 3.6% Higher

Shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Rating) rose 3.6% on Wednesday . The company traded as high as $18.28 and last traded at $18.12. Approximately 284,046 shares changed hands during trading, a decline of 49% from the average daily volume of 559,839 shares. The stock had previously closed at $17.49. Wall Street Analysts […]

Related Keywords

Arizona ,United States ,Melissab Epperly ,Stifel Nicolaus ,Life Insurance Co ,Zentalis Pharmaceuticals Inc ,Institutional Investors Weigh In On Zentalis Pharmaceuticals ,Securities Exchange Commission ,Proshare Advisors ,News Ratings For Zentalis Pharmaceuticals Daily ,Zentalis Pharmaceuticals ,Nasdaq ,Zentalis Pharmaceuticals Price Performance ,Get Rating ,President Cam Gallagher ,Exchange Commission ,State Retirement System ,Financial Advisors ,Share Advisors ,Zentalis Pharmaceuticals Daily ,Nasdaq Zntl ,Zntl ,Medical ,Stocks ,Technicals ,